Changes of retinal oxygen saturation during treatment of diabetic macular edema with a pre-defined regimen of aflibercept: a prospective study

  1. Hasan, Somar ORCID logo
  2. Hammer, Martin
  3. Meller, Daniel

Download
s00417-021-05319-5.pdf 335,70KB
WeightNameValue
1000 Titel
  • Changes of retinal oxygen saturation during treatment of diabetic macular edema with a pre-defined regimen of aflibercept: a prospective study
1000 Autor/in
  1. Hasan, Somar |
  2. Hammer, Martin |
  3. Meller, Daniel |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-09-01
1000 Erschienen in
1000 Quellenangabe
  • 260(2):451-457
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00417-021-05319-5 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786788/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!To study the effect of anti-VEGF therapy for diabetic macular edema (DME) on retinal oxygen saturation (O!##!Methods!#!An interventional prospective single group study. Included were 10 eyes of 10 patients with visually significant DME which received a fixed regimen of intravitreal aflibercept every 4 weeks for 5 months, followed by 3 injections every 8 weeks, and were controlled monthly. Visual acuity (VA), central retinal thickness (CRT), arterial (aO!##!Results!#!The aO2S did not change whereas vO!##!Conclusions!#!During DME treatment with fixed regimen of intravitreal aflibercept over 11 months, we observed a reduction of vO
1000 Sacherschließung
lokal Anti-VEGF therapy
lokal Intravitreal Injections [MeSH]
lokal Retinal oxygen saturation
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Oxygen Saturation [MeSH]
lokal Diabetic Retinopathy/drug therapy [MeSH]
lokal Retina [MeSH]
lokal Tomography, Optical Coherence [MeSH]
lokal Macular Edema/drug therapy [MeSH]
lokal Retinal Disorders
lokal Diabetic macular edema
lokal Macular Edema/diagnosis [MeSH]
lokal Aflibercept
lokal Diabetes Mellitus [MeSH]
lokal Diabetic Retinopathy/complications [MeSH]
lokal Macular Edema/etiology [MeSH]
lokal Receptors, Vascular Endothelial Growth Factor/therapeutic use [MeSH]
lokal Angiogenesis Inhibitors/therapeutic use [MeSH]
lokal Diabetic retinopathy
lokal Diabetic Retinopathy/diagnosis [MeSH]
lokal Recombinant Fusion Proteins/therapeutic use [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-2478-7007|https://frl.publisso.de/adhoc/uri/SGFtbWVyLCBNYXJ0aW4=|https://frl.publisso.de/adhoc/uri/TWVsbGVyLCBEYW5pZWw=
1000 Hinweis
  • DeepGreen-ID: 23221427278c4ae3bd475e79f4e66603 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6450126.rdf
1000 Erstellt am 2023-05-09T11:18:39.139+0200
1000 Erstellt von 322
1000 beschreibt frl:6450126
1000 Zuletzt bearbeitet Sat Oct 21 02:49:19 CEST 2023
1000 Objekt bearb. Sat Oct 21 02:49:19 CEST 2023
1000 Vgl. frl:6450126
1000 Oai Id
  1. oai:frl.publisso.de:frl:6450126 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source